Evidence Based Clinical Chinese Medicine Volume 27 Overweight And Obesity In Adults

The 27th volume of the Evidence-based Clinical Chinese Medicine series examines the management of people who are overweight and obese with Chinese medicine using a 'whole evidence' approach. Overweight and obesity are recognised as leading health concerns worldwide. They have significant impacts on quality of life and mortality and are associated with many complications and chronic illnesses, including diabetes mellitus, cardiovascular disease, hypertension, stroke and some cancers. Conventional medicine understanding of weight gain, including common causes, diagnosis and treatment are included, along with the Chinese medicine conceptualisation of overweight and obesity.Evidence from clinical studies is reviewed using internationally accepted scientific methods. Systematic reviews describe the treatments used in clinical studies, and analyse the effectiveness of Chinese herbal medicines, acupuncture and related therapies, other Chinese medicine therapies, and combinations of Chinese medicine therapies. Experimental studies that describe the potential mechanisms of action of key herbs are summarised. The final chapter synthesises the current evidence and offers suggestions for contemporary clinical practice and future research.This book is a handy desktop reference for both clinicians and students of Chinese and integrative medicine. It provides a comprehensive synthesis of both traditional and contemporary knowledge that can inform clinical decision-making.

The 27th volume of the Evidence-based Clinical Chinese Medicine series examines the management of people who are overweight and obese with Chinese medicine using a 'whole evidence' approach. Overweight and obesity are recognised as leading health concerns worldwide. They have significant impacts on quality of life and mortality and are associated with many complications and chronic illnesses, including diabetes mellitus, cardiovascular disease, hypertension, stroke and some cancers. Conventional medicine understanding of weight gain, including common causes, diagnosis and treatment are included, along with the Chinese medicine conceptualisation of overweight and obesity. Evidence from clinical studies is reviewed using internationally accepted scientific methods. Systematic reviews describe the treatments used in clinical studies, and analyse the effectiveness of Chinese herbal medicines, acupuncture and related therapies, other Chinese medicine therapies, and combinations of Chinese medicine therapies. Experimental studies that describe the potential mechanisms of action of key herbs are summarised. The final chapter synthesises the current evidence and offers suggestions for contemporary clinical practice and future research. This book is a handy desktop reference for both clinicians and students of Chinese and integrative medicine. It provides a comprehensive synthesis of both traditional and contemporary knowledge that can inform clinical decision-making.

Irritable bowel syndrome is a type of functional bowel disorder causing symptoms of abdominal pain and altered bowel habits such as diarrhoea (IBS-D) and constipation (IBS-C). This book uses the 'whole evidence' approach to give an overview of the available evidence for Chinese medicine treatment for irritable bowel syndrome, particularly subtypes IBS-D and IBS-C.The book starts by summarising the conventional understanding of irritable bowel syndrome, including its subtypes, aetiology, diagnosis and current available treatments. Data from Chinese medicine classical literature and clinical studies are then discussed. Evidence from clinical studies are evaluated using high-quality and rigorous scientific methodology. For IBS-D and IBS-C, evidence from treatment modalities including Chinese herbal medicine, acupuncture and combination Chinese medicine therapies are presented. The findings are analysed and potential implications for clinical practice and research are explored. Experimental studies that describe the potential mechanisms of action of key herbs are summarised. In the final chapter, current evidence of Chinese medicine for IBS-D and IBS-C are synthesised, recommendations for contemporary clinical practice and future research are also offered.The book is a helpful guide for clinicians and students of Chinese and integrative medicine, offering a comprehensive synthesis of both classical and contemporary knowledge that can integrated into their clinical practice for people with irritable bowel syndrome.

Type 2 diabetes mellitus is a chronic progressive disease characterised by hyperglycaemia. It affects many people around the world and creates burden for the individual as well as the economy. Chinese medicine can be used to support the management of Type 2 diabetes mellitus symptoms. Chapter 1 of the book summarises the conventional understanding of Type 2 diabetes mellitus, including aetiology, diagnosis and current available treatments.This book uses the 'whole evidence' approach to give an overview of the available evidence for Chinese medicine treatment for Type 2 diabetes mellitus, from classical literature to clinical evidence. Evidence from clinical studies are evaluated using high-quality and rigorous scientific methodology. Clinical trial literature of Chinese medicine treatments for Type 2 diabetes mellitus are described, with treatment modalities including Chinese herbal medicine, acupuncture and other Chinese medicine therapies. The findings are analysed and potential implications for clinical practice and research are explored. Experimental studies that describe the potential mechanisms of action of key herbs are summarised. Current evidence of Chinese medicine for Type 2 diabetes mellitus is synthesised in the final chapter, and suggestions for contemporary clinical practice and future research are also offered.Targeted at clinicians and students of Chinese and integrative medicine, this book is a convenient reference that provides comprehensive synthesis of both classical and contemporary knowledge, which can support and be incorporated into their clinical practice.

Of evidence-based recommendations -- Introduction -- Overweight and obesity: background -- Examination of randomized controlled trial evidence -- Treatment guidelines -- Summary of recommendations -- Future research.

Cardiovascular, respiratory, and related conditions cause more than 40 percent of all deaths globally, and their substantial burden is rising, particularly in low- and middle-income countries (LMICs). Their burden extends well beyond health effects to include significant economic and societal consequences. Most of these conditions are related, share risk factors, and have common control measures at the clinical, population, and policy levels. Lives can be extended and improved when these diseases are prevented, detected, and managed. This volume summarizes current knowledge and presents evidence-based interventions that are effective, cost-effective, and scalable in LMICs.